India Pharmaceutical Market Size, Share and Outlook 2025-2033

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-203

Market Growth Rate: 11.32% (2025-203)

With a strong domestic market and a robust export-oriented manufacturing base, India’s pharmaceutical industry is poised for continued growth. According to the latest report by IMARC Group, the India pharmaceutical market size reached USD 61.36 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 174.31 Billion by 2033, exhibiting a growth rate (CAGR) of 11.32% during 2025-2033.

India Pharmaceutical Industry Trends and Drivers:

A combination of factors such as expanding population, rising healthcare needs, as well as increasing prevalence of chronic and lifestyle-related diseases are responsible for the growth of the India pharmaceutical market. Additionally, the market is propelling owing to the growing health awareness among consumers and the inflating demand for affordable and accessible healthcare solutions. Besides this, the initiatives by government authorities, such as Ayushman Bharat and the Make in India campaign, are boosting pharmaceutical production and improving healthcare infrastructure. India’s reputation as a leading producer of generic drugs, coupled with significant exports to global markets, is further propelling the market. The increasing penetration of health insurance and the growing adoption of preventive healthcare practices are also catalyzing demand for pharmaceutical products across the country.

Emerging trends in the India pharmaceutical market include the rapid use of advanced technologies and research and development (R&D) investments to create innovative treatments. The focus on biologics, biosimilars, and personalized medicine is gaining traction as companies aim to address unmet medical needs. Digital health tools and telemedicine are reshaping the industry, improving access to healthcare, and streamlining patient management. Furthermore, the COVID-19 pandemic has accelerated the demand for vaccines, antiviral drugs, and diagnostic solutions, highlighting the importance of a robust pharmaceutical sector. The market is also witnessing a shift towards environmentally sustainable practices, with manufacturers adopting green chemistry and sustainable production methods. Apart from this, the rise of e-pharmacies and online distribution channels is enhancing accessibility and convenience for consumers, which is anticipated to drive the India pharmaceutical market over the forecasted period.

Grab a sample PDF of this report: 

India Pharmaceutical Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

• Pharmaceutical Drugs
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorder Drugs
  • Musculoskeletal Disorder Drugs
  • Central Nervous System Drugs
  • Oncology Drugs
  • Ophthalmology Drugs
  • Respiratory Diseases Drugs
• Biologics
  • Monoclonal Antibodies (MAbS)
  • Therapeutic Proteins
  • Vaccines

Breakup by Nature:

• Organic
• Conventional

Breakup by Region:

• North India
• West and Central India
• South India
• East India

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Abbott India Ltd (Abbott Laboratories)
• Aurobindo Pharma Limited
• Biocon Limited
• Cadila Pharmaceuticals Ltd.
• Cipla Ltd.
• Divi’s Laboratories Limited
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
• Lupin Limited
• Mankind Pharma
• Merck Life Science Private Limited (Merck KGaA)
• Novartis India Limited (Novartis AG)
• Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
• Procter & Gamble Health Limited (The Procter & Gamble Company)
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd. (Torrent Group)

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-203)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.